GlassScriptPhysician profile
Michael A Secor
NPI 1194880773
$14,666.03
in general payments reported to CMS, 2019-2025
60 companies · $3,179 in 2025
The $3,179 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,891 · 2022: $2,657 · 2023: $2,614 · 2024: $3,326 · 2025: $3,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,966 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,966.33 |
| Education | $152.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,584.67 | 2021-2025 | Briviact, Zilbrysq, Rystiggo |
| Abbvie INC. | $1,412.90 | 2021-2025 | |
| Sk Life Science, INC. | $702.00 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $693.58 | 2021-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $679.56 | 2021-2025 | Ingrezza, Ongentys |
| Mdd US Operations, LLC | $620.54 | 2022-2025 | Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $556.54 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Argenx US, INC. | $536.31 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurelis, INC. | $497.94 | 2021-2025 | Valtoco |
| Kyowa Kirin, INC. | $447.10 | 2021-2024 | Nourianz |
| Pfizer INC. | $422.19 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $413.15 | 2021-2025 | Crexont, Lyvispah, Rytary |
| Lilly USA, LLC | $381.60 | 2022-2025 | Emgality, Amyvid, Kisunla |
| Novartis Pharmaceuticals Corporation | $369.06 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $361.30 | 2021-2025 | Wainua |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Secor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.